CRYO-CELL INTERNATIONAL, INC. Income Taxes Paid
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Income Taxes Paid of $77.08 thousand for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for the quarter ending 2026-05-31 was $77.08K, a 96.49% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for the quarter ending 2026-02-28 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for the quarter ending 2025-11-30 was $1.76M, a 430.56% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for the quarter ending 2025-08-31 was $635.41K, a 46.88% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for fiscal 2025 was $4.59M, a 69.11% increase from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for fiscal 2024 was $2.72M, a 49.22% increase from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for fiscal 2023 was $1.82M, a 15.78% increase from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. income taxes paid, net for fiscal 2022 was $1.57M, a 55.49% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-05-31 | $77.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $77.08K 10-Q · filed 2026-07-15 | $1.84M derived: sum of 3 quarters · filed 2026-07-15 | $2.47M derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-02-28 | $0.00 10-Q · filed 2026-04-14 | $1.76M derived: sum of 2 quarters · filed 2026-04-14 | $2.40M derived: sum of 3 quarters · filed 2026-04-14 | $4.59M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-11-30 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.40M derived: sum of 2 quarters · filed 2026-02-27 | $4.59M derived: sum of 3 quarters · filed 2026-07-15 | $4.59M 10-K · filed 2026-02-27 |
| 2025-08-31 | $635.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $2.83M derived: sum of 2 quarters · filed 2026-07-15 | $2.83M 10-Q · filed 2025-10-15 | $3.17M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-05-31 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $2.20M 10-Q · filed 2026-07-15 | $2.53M derived: sum of 3 quarters · filed 2026-07-15 | $2.96M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-02-28 | $0.00 10-Q · filed 2026-04-14 | $331.90K derived: sum of 2 quarters · filed 2026-04-14 | $764.49K derived: sum of 3 quarters · filed 2026-04-14 | $2.66M derived: sum of 4 quarters · filed 2026-04-14 |
| 2024-11-30 | $331.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $764.49K derived: sum of 2 quarters · filed 2026-02-27 | $2.66M derived: sum of 3 quarters · filed 2026-02-27 | $2.72M 10-K · filed 2026-02-27 |
| 2024-08-31 | $432.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $2.33M derived: sum of 2 quarters · filed 2025-10-15 | $2.39M 10-Q · filed 2025-10-15 | $2.70M derived: sum of 4 quarters · filed 2025-10-15 |
| 2024-05-31 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | $1.95M 10-Q · filed 2025-07-15 | $2.27M derived: sum of 3 quarters · filed 2025-07-15 | $2.79M derived: sum of 4 quarters · filed 2025-07-15 |
| 2024-02-29 | $57.63K 10-Q · filed 2025-04-14 | $373.79K derived: sum of 2 quarters · filed 2025-04-14 | $894.78K derived: sum of 3 quarters · filed 2025-04-14 | $1.85M derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | $316.15K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $837.15K derived: sum of 2 quarters · filed 2025-02-28 | $1.79M derived: sum of 3 quarters · filed 2025-02-28 | $1.82M 10-K · filed 2025-02-28 |
| 2023-08-31 | $521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-15 | $1.47M derived: sum of 2 quarters · filed 2024-10-15 | $1.50M 10-Q · filed 2024-10-15 | $1.70M derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $950.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-15 | $983.65K 10-Q · filed 2024-07-15 | $1.18M derived: sum of 3 quarters · filed 2024-07-15 | $1.80M derived: sum of 4 quarters · filed 2024-07-15 |
| 2023-02-28 | $33.07K 10-Q · filed 2024-04-15 | $228.54K derived: sum of 2 quarters · filed 2024-04-15 | $849.54K derived: sum of 3 quarters · filed 2024-04-15 | $1.61M derived: sum of 4 quarters · filed 2024-04-15 |
| 2022-11-30 | $195.47K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $816.47K derived: sum of 2 quarters · filed 2024-02-28 | $1.57M derived: sum of 3 quarters · filed 2024-02-28 | $1.57M 10-K · filed 2024-02-28 |
| 2022-08-31 | $621.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-12 | $1.38M derived: sum of 2 quarters · filed 2023-10-12 | $1.38M 10-Q · filed 2023-10-12 | $3.01M derived: sum of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | $755.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-14 | $756.13K 10-Q · filed 2023-07-14 | $2.39M derived: sum of 3 quarters · filed 2023-07-14 | $2.39M derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | $644.00 10-Q · filed 2023-04-21 | $1.63M derived: sum of 2 quarters · filed 2023-04-21 | $1.63M derived: sum of 3 quarters · filed 2023-04-21 | |
| 2021-11-30 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.63M derived: sum of 2 quarters · filed 2023-02-28 | $3.53M 10-K · filed 2023-02-28 | |
| 2021-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-18 | $1.90M 10-Q · filed 2022-10-18 | ||
| 2021-05-31 | $1.90M 10-Q · filed 2022-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |